EpiCept NP-1: Interim Phase IIb data

Interim data from 370 evaluable patients in a double-blind Phase IIb

Read the full 113 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE